Clinical Trial: Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases

U.S., June 11 -- ClinicalTrials.gov registry received information related to the study (NCT07638709) titled 'Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases' on June 04.

Brief Summary: The goal of this observational study is to learn about the effects of the timing of radiation therapy and immunotherapy in adults with non-small cell lung cancer (NSCLC) that has spread to the brain. The main questions it aims to answer are:

1. Does the timing of the two treatments change how long the brain tumor stays stable and how long participants live?

2. What medical problems do participants have when receiving these treatments at different times?

3. How does the timing of treatments affect the body's immune system?

Researcher...